However, some mutations in CCNF have been identified as “accelerants” in breast cancer,[4] as well as in Burkitt lymphoma.[5] In addition, methylation analysis of the CCNF gene showed that CCNF has a tendency to be highly expressed in liver cancer tissues. This evidence concerns the gene CCNF and Burkitt lymphoma.